CPS1 and lung adenocarcinoma: There was a trend towards a worse outcome (p = 0.07) in patients exhibiting the lowest quartile of NAGS mRNA expression in lung adenocarcinoma (Figure 2G), while the outcome was worse for patients with the highest CPS1 mRNA expression in lung adenocarcinoma (Figure 2H).